The latest study on Next-Generation Biologics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Next-Generation Biologics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Next-Generation Biologics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Allergan
Bayer
Biogen Idec
Eli Lilly
Kyowa Hakko Kirin
Molecular Partners
Novo Nordisk
Pfizer
Roche
Sanofi
Next-Generation Biologics Market Analysis By Type Segment:
Antibodies
Regenerative medicine
Insulins
Growth hormones
Other
Next-Generation Biologics Market Analysis By Application Segment:
Medical
Scientific Research
Other
Next-Generation Biologics Market Analysis By Regions (Countries):
The Next-Generation Biologics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Next-Generation Biologics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Next-Generation Biologics Market:
Next-Generation Biologics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Next-Generation Biologics Market status and future forecast.
To present the key Next-Generation Biologics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Next-Generation Biologics Market Size Growth Rate by Type (2016-2027)
1.4.2 Antibodies
1.4.3 Regenerative medicine
1.4.4 Insulins
1.4.5 Growth hormones
1.4.6 Other
1.5 Market by Application
1.5.1 Global Next-Generation Biologics Market Share by Application (2016-2027)
1.5.2 Medical
1.5.3 Scientific Research
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Next-Generation Biologics Market Size
2.2 Next-Generation Biologics Growth Trends by Regions
2.2.1 Next-Generation Biologics Market Size by Regions (2016-2027)
2.2.2 Next-Generation Biologics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Next-Generation Biologics Market Size by Manufacturers
3.1.1 Global Next-Generation Biologics Revenue by Manufacturers (2020)
3.1.2 Global Next-Generation Biologics Revenue Market Share by Manufacturers (2020)
3.1.3 Global Next-Generation Biologics Market Concentration Ratio (CR5 and HHI)
3.2 Next-Generation Biologics Key Players Head office and Area Served
3.3 Key Players Next-Generation Biologics Product/Solution/Service
3.4 Date of Enter into Next-Generation Biologics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Next-Generation Biologics Market Size by Type (2016-2020)
4.2 Global Next-Generation Biologics Market Size by Application (2016-2020)
5 United States
5.1 United States Next-Generation Biologics Market Size (2016-2020)
5.2 Next-Generation Biologics Key Players in United States
5.3 United States Next-Generation Biologics Market Size by Type
5.4 United States Next-Generation Biologics Market Size by Application
6 Europe
6.1 Europe Next-Generation Biologics Market Size (2016-2020)
6.2 Next-Generation Biologics Key Players in Europe
6.3 Europe Next-Generation Biologics Market Size by Type
6.4 Europe Next-Generation Biologics Market Size by Application
7 China
7.1 China Next-Generation Biologics Market Size (2016-2020)
7.2 Next-Generation Biologics Key Players in China
7.3 China Next-Generation Biologics Market Size by Type
7.4 China Next-Generation Biologics Market Size by Application
8 Japan
8.1 Japan Next-Generation Biologics Market Size (2016-2020)
8.2 Next-Generation Biologics Key Players in Japan
8.3 Japan Next-Generation Biologics Market Size by Type
8.4 Japan Next-Generation Biologics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Next-Generation Biologics Market Size (2016-2020)
9.2 Next-Generation Biologics Key Players in Southeast Asia
9.3 Southeast Asia Next-Generation Biologics Market Size by Type
9.4 Southeast Asia Next-Generation Biologics Market Size by Application
10 India
10.1 India Next-Generation Biologics Market Size (2016-2020)
10.2 Next-Generation Biologics Key Players in India
10.3 India Next-Generation Biologics Market Size by Type
10.4 India Next-Generation Biologics Market Size by Application
11 Central & South America
11.1 Central & South America Next-Generation Biologics Market Size (2016-2020)
11.2 Next-Generation Biologics Key Players in Central & South America
11.3 Central & South America Next-Generation Biologics Market Size by Type
11.4 Central & South America Next-Generation Biologics Market Size by Application
12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Next-Generation Biologics Introduction
12.1.4 Allergan Revenue in Next-Generation Biologics Business (2020)
12.1.5 Allergan Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Next-Generation Biologics Introduction
12.2.4 Bayer Revenue in Next-Generation Biologics Business (2020)
12.2.5 Bayer Recent Development
12.3 Biogen Idec
12.3.1 Biogen Idec Company Details
12.3.2 Company Description and Business Overview
12.3.3 Next-Generation Biologics Introduction
12.3.4 Biogen Idec Revenue in Next-Generation Biologics Business (2020)
12.3.5 Biogen Idec Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 Next-Generation Biologics Introduction
12.4.4 Eli Lilly Revenue in Next-Generation Biologics Business (2020)
12.4.5 Eli Lilly Recent Development
12.5 Kyowa Hakko Kirin
12.5.1 Kyowa Hakko Kirin Company Details
12.5.2 Company Description and Business Overview
12.5.3 Next-Generation Biologics Introduction
12.5.4 Kyowa Hakko Kirin Revenue in Next-Generation Biologics Business (2020)
12.5.5 Kyowa Hakko Kirin Recent Development
12.6 Molecular Partners
12.6.1 Molecular Partners Company Details
12.6.2 Company Description and Business Overview
12.6.3 Next-Generation Biologics Introduction
12.6.4 Molecular Partners Revenue in Next-Generation Biologics Business (2020)
12.6.5 Molecular Partners Recent Development
12.7 Novo Nordisk
12.7.1 Novo Nordisk Company Details
12.7.2 Company Description and Business Overview
12.7.3 Next-Generation Biologics Introduction
12.7.4 Novo Nordisk Revenue in Next-Generation Biologics Business (2020)
12.7.5 Novo Nordisk Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Next-Generation Biologics Introduction
12.8.4 Pfizer Revenue in Next-Generation Biologics Business (2020)
12.8.5 Pfizer Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Next-Generation Biologics Introduction
12.9.4 Roche Revenue in Next-Generation Biologics Business (2020)
12.9.5 Roche Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Next-Generation Biologics Introduction
12.10.4 Sanofi Revenue in Next-Generation Biologics Business (2020)
12.10.5 Sanofi Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Next-Generation Biologics Key Market Segments
Table Key Players Next-Generation Biologics Covered
Table Global Next-Generation Biologics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Next-Generation Biologics Market Size Market Share by Type 2016-2027
Figure Antibodies Figures
Table Key Players of Antibodies
Figure Regenerative medicine Figures
Table Key Players of Regenerative medicine
Figure Insulins Figures
Table Key Players of Insulins
Figure Growth hormones Figures
Table Key Players of Growth hormones
Figure Other Figures
Table Key Players of Other
Table Global Next-Generation Biologics Market Size Growth by Application 2016-2027 (Million US$)
Figure Medical Case Studies
Figure Scientific Research Case Studies
Figure Other Case Studies
Figure Next-Generation Biologics Report Years Considered
Table Global Next-Generation Biologics Market Size 2016-2027 (Million US$)
Figure Global Next-Generation Biologics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Next-Generation Biologics Market Size by Regions 2016-2027 (Million US$)
Table Global Next-Generation Biologics Market Size by Regions 2016-2020 (Million US$)
Table Global Next-Generation Biologics Market Share by Regions 2016-2020
Figure Global Next-Generation Biologics Market Share by Regions 2016-2020
Figure Global Next-Generation Biologics Market Share by Regions 2020
Table Market Top Trends
Table Global Next-Generation Biologics Revenue by Manufacturers (2020) (Million US$)
Table Global Next-Generation Biologics Market Share by Manufacturers (2020)
Figure Global Next-Generation Biologics Market Share by Manufacturers in 2020
Table Global Next-Generation Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Next-Generation Biologics Product/Solution/Service
Table Date of Enter into Next-Generation Biologics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Next-Generation Biologics Market Size by Type (2016-2020) (Million US$)
Table Global Next-Generation Biologics Market Size Share by Type (2016-2020)
Figure Global Next-Generation Biologics Market Size Market Share by Type (2016-2020)
Table Global Next-Generation Biologics Market Size by Application (2016-2020) (Million US$)
Table Global Next-Generation Biologics Market Size Share by Application (2016-2020)
Figure Global Next-Generation Biologics Market Size Market Share by Application (2016-2020)
Figure Global Next-Generation Biologics Revenue Market Share by Application in 2020
Figure United States Next-Generation Biologics Market Size 2016-2020 (Million US$)
Table United States Key Players Next-Generation Biologics Revenue (2020) (Million US$)
Table United States Key Players Next-Generation Biologics Market Share (2020)
Table United States Next-Generation Biologics Market Size by Type (2016-2020) (Million US$)
Table United States Next-Generation Biologics Market Share by Type (2016-2020)
Table United States Next-Generation Biologics Market Size by Application (2016-2020) (Million US$)
Table United States Next-Generation Biologics Market Share by Application (2016-2020)
Figure Europe Next-Generation Biologics Market Size 2016-2020 (Million US$)
Table Europe Key Players Next-Generation Biologics Revenue (2020) (Million US$)
Table Europe Key Players Next-Generation Biologics Market Share (2020)
Table Europe Next-Generation Biologics Market Size by Type (2016-2020) (Million US$)
Table Europe Next-Generation Biologics Market Share by Type (2016-2020)
Table Europe Next-Generation Biologics Market Size by Application (2016-2020) (Million US$)
Table Europe Next-Generation Biologics Market Share by Application (2016-2020)
Figure China Next-Generation Biologics Market Size 2016-2020 (Million US$)
Table China Key Players Next-Generation Biologics Revenue (2020) (Million US$)
Table China Key Players Next-Generation Biologics Market Share (2020)
Table China Next-Generation Biologics Market Size by Type (2016-2020) (Million US$)
Table China Next-Generation Biologics Market Share by Type (2016-2020)
Table China Next-Generation Biologics Market Size by Application (2016-2020) (Million US$)
Table China Next-Generation Biologics Market Share by Application (2016-2020)
Figure Japan Next-Generation Biologics Market Size 2016-2020 (Million US$)
Table Japan Key Players Next-Generation Biologics Revenue (2020) (Million US$)
Table Japan Key Players Next-Generation Biologics Market Share (2020)
Table Japan Next-Generation Biologics Market Size by Type (2016-2020) (Million US$)
Table Japan Next-Generation Biologics Market Share by Type (2016-2020)
Table Japan Next-Generation Biologics Market Size by Application (2016-2020) (Million US$)
Table Japan Next-Generation Biologics Market Share by Application (2016-2020)
Figure Southeast Asia Next-Generation Biologics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Next-Generation Biologics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Next-Generation Biologics Market Share (2020)
Table Southeast Asia Next-Generation Biologics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Next-Generation Biologics Market Share by Type (2016-2020)
Table Southeast Asia Next-Generation Biologics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Next-Generation Biologics Market Share by Application (2016-2020)
Figure India Next-Generation Biologics Market Size 2016-2020 (Million US$)
Table India Key Players Next-Generation Biologics Revenue (2020) (Million US$)
Table India Key Players Next-Generation Biologics Market Share (2020)
Table India Next-Generation Biologics Market Size by Type (2016-2020) (Million US$)
Table India Next-Generation Biologics Market Share by Type (2016-2020)
Table India Next-Generation Biologics Market Size by Application (2016-2020) (Million US$)
Table India Next-Generation Biologics Market Share by Application (2016-2020)
Figure Central & South America Next-Generation Biologics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Next-Generation Biologics Revenue (2020) (Million US$)
Table Central & South America Key Players Next-Generation Biologics Market Share (2020)
Table Central & South America Next-Generation Biologics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Next-Generation Biologics Market Share by Type (2016-2020)
Table Central & South America Next-Generation Biologics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Next-Generation Biologics Market Share by Application (2016-2020)
Table Allergan Company Details
Table Allergan Revenue in Next-Generation Biologics Business (2020) (Million US$)
Figure Allergan Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Allergan Recent Development
Table Bayer Company Details
Table Bayer Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Bayer Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Bayer Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Biogen Idec Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Biogen Idec Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Eli Lilly Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Kyowa Hakko Kirin Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Kyowa Hakko Kirin Recent Development
Table Molecular Partners Company Details
Table Molecular Partners Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Molecular Partners Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Molecular Partners Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Novo Nordisk Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Pfizer Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Roche Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Roche Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Next-Generation Biologics Business (2020)(Million US$)
Figure Sanofi Revenue Growth Rate in Next-Generation Biologics Business (2020)
Table Sanofi Recent Development
Table Global Next-Generation Biologics Market Size by Regions (Million US$) 2021-2027
Figure Global Next-Generation Biologics Market Size Share by Regions (2021-2027)
Figure Global Next-Generation Biologics Market Size Share by Regions in 2027
Figure United States Next-Generation Biologics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Next-Generation Biologics Market Size Forecast (2021-2027)(Million USD)
Figure China Next-Generation Biologics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Next-Generation Biologics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Next-Generation Biologics Market Size Forecast (2021-2027)(Million USD)
Figure India Next-Generation Biologics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Next-Generation Biologics Market Size Forecast (2021-2027)(Million USD)
Table Global Next-Generation Biologics Market Size by Product (2021-2027) (Million US$)
Figure Global Next-Generation Biologics Market Size by Product (2021-2027)
Figure Global Next-Generation Biologics Market Size by Product in 2027
Table Global Next-Generation Biologics Market Size by Application (2021-2027) (Million US$)
Figure Global Next-Generation Biologics Market Size by Application (2021-2027)
Figure Global Next-Generation Biologics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources